The influence of beta-blockers on delayed memory function in people with cognitive impairment.
about
Successful therapies for Alzheimer's disease: why so many in animal models and none in humans?Carvedilol as a potential novel agent for the treatment of Alzheimer's disease.The Alzheimer's Prevention Clinic at Weill Cornell Medical College / New York - Presbyterian Hospital: Risk Stratification and Personalized Early Intervention.A Comparison of Cognitive and Everyday Functional Performance among Older Adults With and Without Hypertension.Blood pressure and dementia - a comprehensive review.β-Arrestin-biased signaling mediates memory reconsolidation.Evidence-Based Heart Failure Medications and Cognition.The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain.The effects of beta2 adrenergic receptor gene polymorphism in lipid profilesThe relationship between type 2 diabetes and dementia.The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.Safe prescribing of physical health medication in patients with dementia.Catecholamine-Based Treatment in AD Patients: Expectations and Delusions.Causes, consequences, and cures for neuroinflammation mediated via the locus coeruleus: noradrenergic signaling system.Monoaminergic neuropathology in Alzheimer's disease.Oxidative stress induced by the Fe/ascorbic acid system or model ischemia in vitro: effect of carvedilol and pyridoindole antioxidant SMe1EC2 in young and adult rat brain tissue.National Trends in Outpatient Antihypertensive Prescribing in People with Dementia in the United States.
P2860
Q26859305-C5C565D8-42D3-4B27-9962-DC29F76373CDQ30497187-CD02AF41-2580-4FC1-B147-AABB679C798BQ33697647-658D1227-A1F8-4EA3-8E6F-7082132DA7C7Q34399201-D359C739-9259-4BAA-93CE-81F896853ACFQ34409397-C15F75C3-2881-4963-9081-974B39458F83Q35377780-0BBB7992-FE37-4F3A-AE4E-F89D33DE7082Q35634758-EADF80A5-1B49-4BB3-ADFC-3693AABB085CQ36600664-67322B0E-EA3C-4737-90F0-9F69E41970EAQ36726291-D7742A63-8B8C-4877-AF97-1F9CE4284715Q37333381-8C9F3722-5D5E-42F1-829A-7A50DC5343BFQ38108100-145AD640-2532-456C-990E-D74C90E38B32Q38237044-291A0B15-69E2-4DDC-AEE9-40698AFB060DQ38497202-4F3EB711-F07F-4E64-A83D-30790E2AC53AQ38770352-17D1AB85-C1BD-400D-8ED0-DBB765E83DE0Q38809649-E5883691-43EC-4577-B733-ED2B7F062905Q42033320-23ADDA8E-9E3F-436F-BE50-1CB4D96D7F56Q52872937-074AB2E0-A96C-4916-8999-89D937DDD669
P2860
The influence of beta-blockers on delayed memory function in people with cognitive impairment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
The influence of beta-blockers ...... ple with cognitive impairment.
@en
The influence of beta-blockers ...... ple with cognitive impairment.
@nl
type
label
The influence of beta-blockers ...... ple with cognitive impairment.
@en
The influence of beta-blockers ...... ple with cognitive impairment.
@nl
prefLabel
The influence of beta-blockers ...... ple with cognitive impairment.
@en
The influence of beta-blockers ...... ple with cognitive impairment.
@nl
P2860
P356
P1476
The influence of beta-blockers ...... ple with cognitive impairment.
@en
P2093
Carol F Lippa
Gediminas Gliebus
P2860
P356
10.1177/1533317506295889
P407
P577
2007-02-01T00:00:00Z